AChR α 8 Antibodies

Santa Cruz Biotechnology features a diverse variety of AChR α 8 monoclonal antibodies for research focused on understanding the acetylcholine receptor alpha 8 subunit. AChR α 8 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The AChR α 8 subunit is a critical component of the nicotinic acetylcholine receptor, which plays a vital role in neurotransmission and muscle contraction. Proper functioning of AChR α 8 is essential for neuromuscular signaling and has implications in various neurological disorders. Understanding the expression and regulation of AChR α 8 can provide insights into therapeutic targets for conditions such as myasthenia gravis and other neuromuscular diseases. Researchers investigating acetylcholine signaling pathways can utilize AChR α 8 monoclonal antibodies to advance their studies. The specificity and reliability of AChR α 8 monoclonal antibodies enable precise detection and characterization of target proteins. Santa Cruz Biotechnology monoclonal antibodies for AChR α 8 continue to support breakthrough discoveries in neuroscience research worldwide.